Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands

European Journal of Pharmacology
E J MolinariM Gopalakrishnan

Abstract

This study examined the binding and functional properties of human alpha7 neuronal nicotinic acetylcholine receptors stably expressed in human embryonic kidney (HEK) 293 cells following chronic treatment with nicotinic receptor ligands. Treatment of cells with (-)-nicotine (100 microM) for 120 h increased the Bmax values of [125I]alpha-bungarotoxin binding 2.5-fold over untreated cells. This effect was concentration-dependent (EC50) = 970 microM) and a 6-fold upregulation was observed with the maximal concentration of (-)-nicotine tested. Also, treatment of cells with ligands of varying intrinsic activities including (+/-)-epibatidine, (2,4)-dimethoxybenzylidene anabaseine (GTS-21) and 1,1-dimethyl-4-phenyl piperazinium iodide (DMPP) also upregulated [125I]alpha-bungarotoxin binding. A concentration-dependent upregulation of binding sites was also observed following treatment with the alpha7 nicotinic receptor antagonist, methyllycaconitine (EC50 = 92 microM) with a maximal upregulation of about 7-fold. Functionally, the peak amplitude of the whole-cell currents recorded by fast application of (-)-nicotine after chronic treatment of cells with concentrations of (-)-nicotine (1000 microM) or methyllycaconitine (10 microM) that e...Continue Reading

References

Dec 11, 1992·Trends in Neurosciences·J L Franklin, E M Johnson
Oct 26, 1992·Neuroscience Letters·D BertrandM Ballivet
Jun 1, 1990·Trends in Pharmacological Sciences·S Wonnacott
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J BoulterJ Patrick
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Jun 1, 1995·Neuropharmacology·C A BriggsM Piattoni-Kaplan
Aug 15, 1995·European Journal of Pharmacology·M GopalakrishnanJ P Sullivan
Jan 1, 1995·Annual Review of Physiology·D S McGehee, L W Role
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·N L Benowitz
Dec 13, 1997·Molecular Neurobiology·J Lindstrom

❮ Previous
Next ❯

Citations

Nov 26, 2009·Psychopharmacology·Elysia SmallAdrie W Bruijnzeel
Jun 8, 2007·Cellular and Molecular Neurobiology·Enrique L M Ochoa, Jose Lasalde-Dominicci
Aug 12, 2009·Journal of Molecular Neuroscience : MN·Danyan Mao, Daniel S McGehee
Jun 27, 2003·European Journal of Pharmacology·Riad SeddikJérôme Trouslard
Jul 6, 2000·Archives of Medical Research·S Mihailescu, R Drucker-Colín
Apr 12, 2000·Progress in Neurobiology·D Paterson, A Nordberg
Feb 24, 2001·Journal of Chemical Neuroanatomy·J A CourtE Perry
Apr 2, 2005·Nature Reviews. Drug Discovery·Andrew K JonesDavid B Sattelle
Dec 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Young-Hwan JoLorna W Role
Oct 25, 2000·Neuropharmacology·L M HoulihanI Bermudez
May 16, 2002·British Journal of Pharmacology·Francisco SalaSalvador Sala
Dec 30, 2008·Neurochemistry International·M Mousavi, E Hellström-Lindahl
Dec 13, 2012·Expert Opinion on Therapeutic Targets·Tanya L Wallace, Daniel Bertrand
Feb 13, 2017·The Journal of Physiology·Veronika J Baumann, Ursula Koch
May 26, 2005·Brain Research. Brain Research Reviews·Hai Wang, Xiulan Sun
Feb 7, 2004·The Journal of Biological Chemistry·Jérôme SallettePierre Jean Corringer
Nov 19, 2002·Journal of Neurobiology·Michael W Quick, Robin A J Lester
Nov 19, 2002·Journal of Neurobiology·Huibert D Mansvelder, Daniel S McGehee
Jun 2, 2005·The European Journal of Neuroscience·Jukka S PakkanenRaimo K Tuominen
May 3, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Juan ArredondoSergei A Grando
Oct 20, 2006·Journal of Neurophysiology·Xiaochuan Guo, Robin A J Lester
Jan 16, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Vincent LaudenbachPierre Gressens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.